These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22763037)

  • 1. Comparison of brain and blood gene expression in an animal model of negative symptoms in schizophrenia.
    Bosker FJ; Gladkevich AV; Pietersen CY; Kooi KA; Bakker PL; Gerbens F; den Boer JA; Korf J; te Meerman G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):142-8. PubMed ID: 22763037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat.
    Pietersen CY; Bosker FJ; Postema F; Fokkema DS; Korf J; den Boer JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1209-18. PubMed ID: 16626845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
    Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of Troponin T1 gene is induced by ketamine in adult mouse brain.
    Lowe XR; Lu X; Marchetti F; Wyrobek AJ
    Brain Res; 2007 Oct; 1174():7-17. PubMed ID: 17850769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI).
    Yu H; Li Q; Wang D; Shi L; Lu G; Sun L; Wang L; Zhu W; Mak YT; Wong N; Wang Y; Pan F; Yew DT
    Neurotoxicology; 2012 Jan; 33(1):70-7. PubMed ID: 22178134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
    Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
    Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures.
    Skórzewska A; Bidziński A; Lehner M; Turzyńska D; Wisłowska-Stanek A; Sobolewska A; Szyndler J; Maciejak P; Taracha E; Płaźnik A
    Pharmacol Biochem Behav; 2006 Nov; 85(3):522-34. PubMed ID: 17107707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain.
    Watanabe M; Yoshikawa M; Takeyama K; Hashimoto A; Kobayashi H; Suzuki T
    Tokai J Exp Clin Med; 2010 Dec; 35(4):137-43. PubMed ID: 21319044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional response to the neuroleptic-like compound Ampullosporin A in the rat ketamine model.
    Krügel H; Becker A; Polten A; Grecksch G; Singh R; Berg A; Seidenbecher C; Saluz HP
    J Neurochem; 2006 Apr; 97 Suppl 1():74-81. PubMed ID: 16635253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures.
    Skórzewska A; Bidziński A; Hamed A; Lehner M; Turzyńska D; Sobolewska A; Maciejak P; Szyndler J; Wisłowska-Stanek A; Płaźnik A
    Horm Behav; 2008 Nov; 54(5):602-12. PubMed ID: 18601929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats.
    de Oliveira L; Spiazzi CM; Bortolin T; Canever L; Petronilho F; Mina FG; Dal-Pizzol F; Quevedo J; Zugno AI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1003-8. PubMed ID: 19454299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral, biochemical and histological studies in a model of pilocarpine-induced spontaneous recurrent seizures.
    Szyndler J; Wierzba-Bobrowicz T; Skórzewska A; Maciejak P; Walkowiak J; Lechowicz W; Turzyńska D; Bidziński A; Płaźnik A
    Pharmacol Biochem Behav; 2005 May; 81(1):15-23. PubMed ID: 15894059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
    Chatterjee M; Ganguly S; Srivastava M; Palit G
    Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model of emotional blunting in schizophrenia.
    Pietersen CY; Bosker FJ; Doorduin J; Jongsma ME; Postema F; Haas JV; Johnson MP; Koch T; Vladusich T; den Boer JA
    PLoS One; 2007 Dec; 2(12):e1360. PubMed ID: 18159243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.
    Lehner M; Taracha E; Turzyńska D; Sobolewska A; Hamed A; Kołomańska P; Skórzewska A; Maciejak P; Szyndler J; Bidziński A; Płaźnik A
    Behav Brain Res; 2008 Oct; 192(2):203-15. PubMed ID: 18499280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
    Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
    Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.